Incorporating patients' perspectives in complementary and alternative medicine clinical trial design

被引:8
作者
Rodeheaver, PF [1 ]
Taylor, AG [1 ]
Lyon, DE [1 ]
机构
[1] Univ Virginia, Ctr Study Complementary & Alternat Therapies, Sch Nursing, Charlottesville, VA 22908 USA
关键词
D O I
10.1089/107555303771952299
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objectives: To describe the importance and process of gathering the perspectives of former patients when designing clinical studies for complementary and alternative medicine (CAM) therapies and to describe how this information was used to guide the planning of a clinical study using complementary modalities to reduce symptom distress and enhance quality of life during the autologous stem cell transplantation (ASCT) process. Design: Structured interviews with former ASCT patients to identify preferences, opinions, and other issues that may affect a clinical study in this population. Setting: University of Virginia Health System Stem Cell Transplant Clinic. Subjects: Ten (10) patients who had undergone ASCT within the previous year. Results: In general, the 10 study participants interviewed reported that they would have been more receptive to receiving gentle Swedish massage than using guided imagery tapes during the ASCT process, although neither modality would have been particularly welcome during those treatment phases with highest physical or emotional/mental stress. Personal experiences, treatment side-effects, "personality," and life situation all had an influence on not only what was considered most stressful for the patient but also why it was perceived as stressful. Conclusion: Eliciting the views of persons who have undergone significant medical events is a necessary step in rigorous clinical trial development aimed at testing the efficacy of CAM modalities for symptom management. Consideration of patient preferences and motivations may ensure the best fit between interventions and the desired outcomes.
引用
收藏
页码:959 / 967
页数:9
相关论文
共 27 条
[1]   Massage therapy for patients undergoing autologous bone marrow transplantation [J].
Ahles, TA ;
Tope, DM ;
Pinkson, B ;
Walch, S ;
Hann, D ;
Whedon, M ;
Dain, B ;
Weiss, JE ;
Mills, L ;
Silberfarb, PM .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 18 (03) :157-163
[2]   Patients' psychosocial concerns following stem cell transplantation [J].
Andrykowski, MA ;
Cordova, MJ ;
Hann, DM ;
Jacobsen, PB ;
Fields, KK ;
Phillips, G .
BONE MARROW TRANSPLANTATION, 1999, 24 (10) :1121-1129
[3]  
Aronson J., 1995, Qual Rep, V2, P1, DOI [DOI 10.46743/2160-3715/1995.2069, 10.46743/2160-3715/1995.2069]
[5]   Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: A longitudinal follow-up of 415 patients [J].
Bush, NE ;
Donaldson, GW ;
Haberman, MH ;
Dacanay, R ;
Sullivan, KM .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (5A) :576-591
[6]  
Carlson Linda E, 2002, Expert Rev Pharmacoecon Outcomes Res, V2, P129, DOI 10.1586/14737167.2.2.129
[7]   Trends in alternative medicine use in the United States, 1990-1997 - Results of a follow-up national survey [J].
Eisenberg, DM ;
Davis, RB ;
Ettner, SL ;
Appel, S ;
Wilkey, S ;
van Rompay, M ;
Kessler, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18) :1569-1575
[8]  
Ezzone S, 1998, Oncol Nurs Forum, V25, P1551
[9]   Approach to Hodgkin's lymphoma in the new millennium [J].
Fung, HC ;
Nademanee, AP .
HEMATOLOGICAL ONCOLOGY, 2002, 20 (01) :1-15
[10]   The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation [J].
Gaston-Johansson, F ;
Fall-Dickson, JM ;
Nanda, J ;
Ohly, KV ;
Stillman, S ;
Krumm, S ;
Kennedy, MJ .
CANCER NURSING, 2000, 23 (04) :277-285